Humatrope is a prominent brand name for somatropin, a recombinant Human Growth Hormone (HGH). It is manufactured globally by Eli Lilly Important Notice: Eli Lilly has announced the permanent, worldwide discontinuation of Humatrope distribution effective December 31, 2026. Patients currently on a regimen are being transitioned to alternative HGH therapies Primary Use: Treats growth failure or severe short stature in pediatric patients (due to growth hormone deficiency, Turner syndrome, or SHOX deficiency) and growth hormone deficiency in adults sing special cartridges paired with a reusable Humatrope Pen device Key Safety Warnings: Completely contraindicated in individuals with active cancer or severe acute respiratory illnesses. It must be handled with strict refrigeration storage (2°C to 8°C); freezing destroys the biologic hormone Because it is a biologic hormone, HGH requires specialized prescriptions and pricing is dictated by the precise dose strength (ranging from 5 mg / 15 IU vials up to 24 mg / 72 IU cartridges)